Bio-Path Holdings, Inc. (NASDAQ:BPTH – Free Report) – Research analysts at Roth Capital upped their Q2 2024 earnings per share estimates for shares of Bio-Path in a research note issued to investors on Wednesday, May 15th. Roth Capital analyst J. Aschoff now forecasts that the company will post earnings of ($2.06) per share for the […]